CATALOGO DEI PRODOTTI DELLA RICERCA

ROSSINI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.302
EU - Europa 23.365
AS - Asia 16.970
SA - Sud America 2.336
Continente sconosciuto - Info sul continente non disponibili 852
AF - Africa 514
OC - Oceania 43
Totale 73.382
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.307
RU - Federazione Russa 7.767
SG - Singapore 7.061
GB - Regno Unito 5.402
CN - Cina 4.609
IT - Italia 3.288
BR - Brasile 1.825
HK - Hong Kong 1.469
DE - Germania 1.418
VN - Vietnam 1.357
FR - Francia 1.270
SE - Svezia 1.106
IE - Irlanda 1.065
FI - Finlandia 863
KR - Corea 555
CA - Canada 443
BD - Bangladesh 410
IN - India 332
UA - Ucraina 319
TR - Turchia 235
JP - Giappone 206
NL - Olanda 183
AR - Argentina 171
MX - Messico 135
NG - Nigeria 130
PL - Polonia 119
ES - Italia 116
IQ - Iraq 104
ID - Indonesia 103
ZA - Sudafrica 85
BE - Belgio 81
IL - Israele 79
EC - Ecuador 78
AT - Austria 75
CO - Colombia 72
CR - Costa Rica 62
PK - Pakistan 53
CL - Cile 52
VE - Venezuela 52
GT - Guatemala 50
SC - Seychelles 50
HN - Honduras 48
RO - Romania 47
UZ - Uzbekistan 47
CW - ???statistics.table.value.countryCode.CW??? 45
PR - Porto Rico 45
TG - Togo 43
NI - Nicaragua 42
SV - El Salvador 40
TT - Trinidad e Tobago 40
BJ - Benin 39
SA - Arabia Saudita 39
MA - Marocco 38
IR - Iran 37
AU - Australia 35
JM - Giamaica 35
LT - Lituania 34
PH - Filippine 32
NP - Nepal 30
PY - Paraguay 28
EG - Egitto 27
PE - Perù 26
KE - Kenya 24
MY - Malesia 24
CH - Svizzera 23
AE - Emirati Arabi Uniti 21
CZ - Repubblica Ceca 21
GR - Grecia 19
JO - Giordania 19
AZ - Azerbaigian 18
TN - Tunisia 17
DZ - Algeria 16
BG - Bulgaria 15
PT - Portogallo 15
BO - Bolivia 14
DO - Repubblica Dominicana 13
HR - Croazia 13
SK - Slovacchia (Repubblica Slovacca) 13
UY - Uruguay 13
EE - Estonia 12
LB - Libano 12
AM - Armenia 11
GP - Guadalupe 11
KG - Kirghizistan 11
OM - Oman 11
TH - Thailandia 10
AL - Albania 9
BH - Bahrain 9
DK - Danimarca 9
PS - Palestinian Territory 9
RS - Serbia 9
EU - Europa 8
KZ - Kazakistan 8
LV - Lettonia 8
NO - Norvegia 8
QA - Qatar 8
SN - Senegal 8
SI - Slovenia 7
A2 - ???statistics.table.value.countryCode.A2??? 6
BB - Barbados 6
Totale 72.442
Salva come PNG Salva come JPEG
Città #
Southend 4.712
Ashburn 3.987
Singapore 3.764
San Jose 2.602
Moscow 2.461
Jacksonville 2.220
Chandler 2.204
Dallas 1.922
Hong Kong 1.439
Woodbridge 1.235
Council Bluffs 1.073
Dublin 1.046
Ann Arbor 959
Verona 799
Beijing 733
Houston 721
The Dalles 717
New York 523
Los Angeles 502
Ho Chi Minh City 450
Princeton 446
Lawrence 443
Wilmington 423
Jinan 326
Nanjing 296
Hanoi 293
Milan 293
Santa Clara 287
Shenyang 281
Buffalo 252
Redmond 237
Bologna 225
Helsinki 215
São Paulo 207
Tokyo 186
Tianjin 181
Sindelfingen 177
Hebei 175
Munich 167
Redondo Beach 158
Rome 150
Columbus 136
Changsha 135
Abuja 126
Boardman 115
Ningbo 113
Zhengzhou 113
Haikou 109
Nanchang 108
Chicago 107
Phoenix 100
Seattle 100
Hangzhou 96
London 96
Warsaw 96
Orem 95
Toronto 95
Denver 94
San Francisco 93
Brooklyn 92
Guangzhou 88
Jiaxing 88
Taizhou 88
Montreal 85
Atlanta 81
Washington 76
Redwood City 72
Frankfurt am Main 70
Brussels 69
Taiyuan 68
Norwalk 67
Falkenstein 65
North Bergen 58
Turku 58
Da Nang 56
Amsterdam 53
Falls Church 52
Naples 52
Chennai 51
Johannesburg 51
Belo Horizonte 50
Boston 50
Las Vegas 50
Rio de Janeiro 50
San José 50
Hyderabad 49
Brasília 48
Fairfield 48
Jakarta 45
Manchester 45
Tashkent 45
Willemstad 45
Mexico City 44
Stockholm 44
Vienna 44
Fuzhou 43
Lomé 43
Dearborn 42
Lanzhou 42
Biên Hòa 41
Totale 43.772
Salva come PNG Salva come JPEG
Nome #
Epidemiology and Economic Burden of Osteoporosis in Italy 467
Fibromialgia. Razionale e risultati del trattamento con L-Acetilcarnitina. 433
Teriparatide and denosumab combination therapy and skeletal metabolism 363
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 357
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 301
Artrite Reumatoide e Metabolismo Minerale 296
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 289
Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis 286
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 285
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 279
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 271
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 266
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 261
Age-related bone loss in postmenopausal women 261
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 260
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 257
Anti-CCP antibodies and bone 255
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 253
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 253
Bone metabolism in patients with anorexia nervosa and amenorrhoea 245
[Therapeutic strategies in osteoporosis: whom and when to treat] 244
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 244
[Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] 242
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 241
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 240
[Risk factors for hip fracture in elderly persons]. 238
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 235
The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes 232
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 230
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 227
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 227
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 225
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 225
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 221
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 221
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 221
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 220
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 220
Bone involvement and osteoporosis in mastocytosis. 218
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 217
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 217
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)]. 215
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 215
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 214
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 211
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 211
Bone involvement in patient with clonal mast cell disorders 210
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 209
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 206
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 205
Incidenza di ipovitaminosi D nel Nord Italia 204
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 204
Prevalence and incidence of rheumatoid arthritis in Italy. 204
Could γ\δ T-cells explain zoledronic acid adverse events? 200
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 200
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 200
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 199
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 196
Rapporti tra sistema immune e metabolismo osseo 196
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 196
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 196
Guidelines for the diagnosis, prevention and management of osteoporosis 194
Osteoporosi: progressi nella diagnosi e nel trattamento 193
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 193
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 192
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 192
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 191
Allergy and the bone: unexpected relationships 190
Osteopetrosi 190
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 190
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 190
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 190
Osteoporosis treatment: why ibandronic acid? 189
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 188
The obesity paradox and osteoporosis 187
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 187
Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases. 186
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 186
Bone Disease in Mastocytosis 185
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 185
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 185
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 185
Association between environmental air pollution and rheumatoid arthritis flares 184
A multi-dimensional questionnaire quantifying quality of life in elderly osteoporotic women: the Italian triple-Q osteoporosis study 183
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 183
Sclerostin and DKK1 in primary hyperparathyroidism. 182
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 181
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 181
Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis 181
DXA bone mineral density in males: retrospective study in real life. 177
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 177
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 177
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis 176
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 176
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 176
Invecchiamento dell'apparato scheletrico 176
ARTROPATIE DISMETABOLICHE 176
Prevalence of osteoporosis in patients affected by mastocytosis 176
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 176
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 176
Totale 22.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 259.867
article - articoli 248.492
book - libri 0
conference - conferenze 3.586
curatela - curatele 0
other - altro 966
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.823
Totale 519.734
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.000 0 0 0 0 153 127 61 184 274 97 302 802
2022/20236.808 556 554 699 1.177 606 1.645 85 384 726 75 226 75
2023/20243.503 178 269 329 417 401 533 179 274 58 128 494 243
2024/20259.506 559 676 406 1.468 469 257 442 467 1.404 807 701 1.850
2025/202627.018 1.935 1.333 1.975 4.336 6.447 1.883 2.711 1.603 2.034 1.296 604 861
2026/20276.810 465 853 1.211 3.555 726 0 0 0 0 0 0 0
Totale 73.382